Institutional investors hold a majority ownership of INCY through the 94.04% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended December 2016, these large investors purchased a net $588.4 thousand shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CITADEL ADVISORS LLC Bought 1.6 Million shares of Incyte Corp
FRED ALGER MANAGEMENT, INC. Bought 1.2 Million shares of Incyte Corp
UBS ASSET MANAGEMENT (AMERICAS) ... Bought 1.1 Million shares of Incyte Corp